I. O. Surikova

I. O. Surikova

Auto-generated profile, based on publicly available information

I. O. Surikova

Національний фармацевтичний університет Міністерства охорони здоров’я України

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 June 2021 in ScienceRise: Pharmaceutical Science
Verified
Journal Article
Open access
PDF file
AKAlla Kotvitska
Alla Kotvitska
Alina VolkovaAlina Volkova
Alina Volkova
IKIuliia Korzh
Iuliia Korzh
ISIryna Surikova
Iryna Surikova
The introduction of national strategies aimed at improving the well-being of the population of the country is one of the current approaches to reforming the public policies of the countries of the world. It is the socioeconomic determinants of health that determine the conditions in which people are born, grow, live and getting old, as well as the spheres of influence on these conditions, such as public policy, state of economic development, demographic trends, etc. The aim. In this way, our research has focused on a comparative analysis of macroeconomic indicators that determine the effectiveness of socioeconomic determinants of healthсare in Europe and Ukraine, that are used to provide scientific justification for the construction of humanistic models for the provision of pharmaceutical care to the population in the context of the rapid stratification of Ukrainian society according to socioeconomic indicators. Materials and methods. The research methodology is based on the principles of systems analysis and an interdisciplinary scientific and systemic approach. The study used the empirical method, the method of comparative analysis and synthesis of statistical data, the graphical method. Results. A comparative analysis of the socioeconomic determinants of health in the countries of the European region and in Ukraine was carried out on three levels of indicators: the level of health-care expenditure, the structure of health-care expenditure and expenditure on medicines. The analysis revealed that in 2019, the average health expenditure of the countries analyzed was 8.2 % of GDP. Only two of the 34 countries - Ukraine and Turkey - have a rate below the 5 % that recommended by WHO. Public health financing schemes and compulsory health insurance are the main funding mechanisms in all countries, with the exception of Cyprus. Ukraine, Russia, Greece, Latvia and Bulgaria have the largest share of direct costs to patients as a source of health care financing. The results of the analysis of the medicine expenditure indicator as a proportion of total health expenditure showed that the highest level was in Bulgaria (35.4 %), the lowest in Denmark (6.4 %). Overall, five countries have high levels of pharmaceutical expenditures. In most European countries, the cost of purchasing medicines has been found to range from 346 to 619 USD per person per year. The highest value of this indicator from the European region is in Switzerland (894 USD per person), and the lowest is in Ukraine (73 USD). Based on the results of the comparative analysis, the countries were grouped according to key indicators into three categories - high, medium and low. Conclusions. A comparative analysis of key indicators of the socio-economic determinants of health in the country of the European region has been carried out

4 October 2017 in Фармацевтичний часопис
Verified
Journal Article
Open access
PDF file
AKA. A. Kotvitska
A. A. Kotvitska
IKI. V. Kubareva
I. V. Kubareva
ISI. O. Surikova
I. O. Surikova
Мета роботи. Вивчення міжнародного досвіду становлення та розвитку соціальної фармації.Матеріали і методи. Аналіз наукових публікацій та офіційних сайтів ВНЗ за допомогою системно-аналітичного та ретроспективного методів аналізу.Результати й обговорення. У статті проаналізовано основні етапи становлення та розвитку соціальної фармації, перші етапи зародження та становлення якої відбулися в 50 рр. ХХ ст. в європейських країнах та США. В 70–80 рр. ХХ ст. відбулося обґрунтування необхідності впровадження соціальних та біхеовіристичних аспектів фармацевтичної діяльності в професійну підготовку фармацевтичних працівників на суспільному та державному рівнях у США та Великій Британії. На початку 2000-х рр. відбулося формування концепції соціальної фармації. Наприкінці 1990-х – у 2010 рр. соціальна фармація як навчальна дисципліна, область наукових досліджень та концепція розвитку фармацевтичного сектора галузі охорони здоров’я впроваджуються в пострадянських країнах та в УкраїніВисновки. У цілому становлення соціальної фармації характеризується обґрунтованою необхідністю впровадження соціальних та біхеовіристичних наук до навчальних програм підготовки фармацевтичних працівників із подальшим включенням соціальної фармації та споріднених дисциплін у навчальні програми, плани, а також створенням структурних підрозділів (кафедр ВНЗ) та центрів з соціальної фармації, що стає передумовою формування концепції соціальної фармації та подальшим впровадження її у практичну діяльність та функціонування фармацевтичного сектора галузі охорони здоров’я.

29 January 2023 in Social Pharmacy in Health Care
Verified
Journal Article
Open access
AKA. A. Kotvitska
A. A. Kotvitska
Alina VolkovaAlina Volkova
Alina Volkova
IKIu. V. Korzh
Iu. V. Korzh
ISI. O. Surikova
I. O. Surikova
OOO. S. Ovakimian
O. S. Ovakimian
OSO. V. Sevriukov
O. V. Sevriukov
Aim. To study pharmaceutical awareness of the population in the rational use of medicines using innovative marketing tools. Materials and methods. The results of an electronic survey of visitors to pharmacies using questionnaires of the author’s social project “Important facts about medicines” implemented by pharmacies are presented. The data analysis was accompanied by the use of sociological survey methods, descriptive statistics, graphic analysis, grouping methods and generalization of data. Results. Based on the data generalization the existing correlation between the level of involving pharmacy visitors in the project with the interest in obtaining important facts about medicines was found. According to the number of responses provided by visitors during the project implementation, it can be argued that the most attractive was the information about the impact of medicines while driving, and half as attractive were the facts about the peculiarities of using medicines for children. It was determined that the most general important facts about medicines were well-known for the project participants; on average 53 % of respondents had a sufficient level of awareness. Thus, the highest level of awareness was determined regarding the side effects in case of simultaneous use of medicines and alcohol; increased blood pressure in case of medicines containing caffeine; strict compliance with the patient information leaflet for taking medicines. A sufficient number of project participants (44 % of the total number of pharmacy visitors who responded) indicated that they were aware of the facts about the peculiarities of using medicines for children under one year of age. The level of pharmaceutical awareness of pharmacy visitors concerning important facts about the effects of medicines on the human body while driving was the lowest; it was 33% among all pharmacy visitors who responded. For example, pharmacy visitors were not aware of what antihistamines should not be taken by drivers. Conclusions. Based on the analysis a high level of self-motivation of visitors to expand the range of important knowledge about medicines and the effectiveness of innovative marketing tools to create pharmaceutical awareness of the population in issues of the rational use of medicines has been revealed. Key words: pharmaceutical information; pharmaceutical awareness of the population; responsible self-medication; social project.

14 May 2019 in Management, economy and quality assurance in pharmacy
Verified
Journal Article
Open access
PDF file
AKA. A. Kotvitska
A. A. Kotvitska
ISI. O. Surikova
I. O. Surikova
Study of negative outcomes in the results of using medicines by patients in Ukraine and abroad

28 March 2025 in Social Pharmacy in Health Care
Verified
Journal Article
Open access
PDF file
AKA.A. Kotvitska
A.A. Kotvitska
ISI. O. Surikova
I. O. Surikova
Alina VolkovaAlina Volkova
Alina Volkova
OSO. O. Surikov
O. O. Surikov
Aim. To analyze regulatory decisions of national authorities on the drug safety. Materials and methods. The study materials were reports of the State Expert Centre of the Ministry of Health of Ukraine (SEC) and the State Service of Ukraine on Medicines and Drugs Control (SSMDC), regulatory acts of the SSMDC, and scientific publications. General scientific and special methods, including content analysis, synthesis, generalization, graphic methods, were used in the study. Results. The analysis of the activities of national regulatory authorities on drug safety allowed us to identify the specificity of the decision-making procedure for suspending/ withdrawing suspected medicines from the circulation and conducting the quality control. Based on the results of monitoring of SRa websites regarding information on the drug safety and data on the SEC recommendations issued regarding the need to make changes to the instructions, update information on the drug safety, implement measures to minimize the risks of serious adverse reactions (ARs), and limit the use of medicines, it was determined that 60% of recommendations concerned changes to the instructions, 34 % of them related to updating information on the drug safety, while other types of recommendations were less than 6 %. The results of the analysis of regulatory decisions of the SSMDC based on information about serious and unforeseen ARs showed that 85 orders were issued to temporarily ban the circulation of medicines within 2020-2023; as a result of additional studies, a decision was made in 22 cases to completely ban the circulation, including 14 cases related to medicines imported to Ukraine as humanitarian aid and did not have the appropriate labeling. The analysis of the list of medicinal products temporarily banned from the circulation has revealed that 94 % of them are presented in the form of parenteral dosage forms, 78 % of the list are medicines of domestic production. Conclusions. The analysis of the activities of the national regulatory authorities on the safety of medicines in Ukraine in 2020-2023 showed that the largest number of orders to temporarily suspend the drug circulation was issued by the State Administration on Medicines in 2023. In almost 60 % of cases, the reason for stopping the drug circulation was the death of a patient, and in 16 % of cases, orders for a complete ban on the circulation concerned medicines imported as humanitarian aid. Taking into account the trends towards changing the structure of national regulatory authorities in the healthcare sector, it is promising to further study the compliance of regulatory activities on safety issues with the international practice of strict regulatory agencies.

11 December 2017 in Social Pharmacy in Health Care
Verified
Journal Article
Open access
PDF file
AKA. A. Kotvitska
A. A. Kotvitska
IKI. V. Kubarieva
I. V. Kubarieva
ISI. O. Surikova
I. O. Surikova
Determination of the content and formation of the concept of social pharmacy in the world and in Ukraine